Dr. Reddy's Laboratories Ltd.
Revolutionary HIV Prevention Tool to be Available at $40 per Year in 120 Low- and Middle-Income Countries Starting in 2027
A groundbreaking partnership between Dr. Reddy's Laboratories, Unitaid, the Clinton Health Access Initiative (CHAI), and Wits RHI will make the HIV prevention tool, injectable lenacapavir, available at a cost of US$40 per year in 120 low- and middle-income countries starting in 2027. The injection has shown exceptional